Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 5
2021 5
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Gómez-Centurión I, Martin Rojas RM, Bailén R, Muñoz C, Sabell S, Oarbeascoa G, Fernández-Caldas P, Carbonell D, Gayoso J, Martínez-Laperche C, Buño I, Anguita J, Díez-Martin JL, Kwon M. Gómez-Centurión I, et al. Among authors: oarbeascoa g. Ann Hematol. 2023 Jun;102(6):1561-1567. doi: 10.1007/s00277-023-05206-5. Epub 2023 Apr 21. Ann Hematol. 2023. PMID: 37083956
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.
de la Iglesia-San Sebastián I, Carbonell D, Bastos-Oreiro M, Pérez-Corral A, Bailén R, Chicano M, Muñiz P, Monsalvo S, Escudero-Fernández A, Oarbeascoa G, Fernández-Caldas P, Gómez-Centurión I, Pion M, Gayoso J, Anguita J, Kwon M, Díez-Martín JL, Buño I, Martínez-Laperche C. de la Iglesia-San Sebastián I, et al. Among authors: oarbeascoa g. Transplant Cell Ther. 2024 Mar;30(3):306.e1-306.e12. doi: 10.1016/j.jtct.2023.12.672. Epub 2024 Jan 5. Transplant Cell Ther. 2024. PMID: 38184148 Free article.
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Bailén R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Vallés A, Esquirol A, Fonseca M, Solán L, Sánchez-Vadillo I, Bautista G, Bento L, López-Godino O, Pérez-Martínez A, Torrent A, Zanabili J, Calbacho M, Moreno MÁ, Pascual-Cascón MJ, Guerra-Domínguez L, Chinea A, García-Cadenas I, López-Corral L, Boix-Giner F, López Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernández-Caldas P, Anguita J, Kwon M. Bailén R, et al. Among authors: oarbeascoa g. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. Front Immunol. 2023. PMID: 37304258 Free PMC article.
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel.
Martín-Rojas RM, Gómez-Centurión I, Bailén R, Bastos M, Diaz-Crespo F, Carbonell D, Correa-Rocha R, Pion M, Muñoz C, Sancho M, Gómez Fernández I, Oarbeascoa G, Pérez-Corral A, Martínez-Laperche C, Anguita J, Buño I, Menárguez J, Díez-Martín JL, Kwon M. Martín-Rojas RM, et al. Among authors: oarbeascoa g. Clin Case Rep. 2022 Jan 7;10(1):e05209. doi: 10.1002/ccr3.5209. eCollection 2022 Jan. Clin Case Rep. 2022. PMID: 35028140 Free PMC article.
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.
Muñiz P, Andrés-Zayas C, Carbonell D, Chicano M, Bailén R, Oarbeascoa G, Suárez-González J, Gómez Centurión I, Dorado N, Gallardo D, Anguita J, Kwon M, Díez-Martín JL, Martínez-Laperche C, Buño I. Muñiz P, et al. Among authors: oarbeascoa g. Front Immunol. 2022 Sep 23;13:1002959. doi: 10.3389/fimmu.2022.1002959. eCollection 2022. Front Immunol. 2022. PMID: 36211438 Free PMC article.
Clinical grade production of IL-15 stimulated NK cells for early infusion in adult AML patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Rubio-Azpeitia E, Pérez-Corral AM, Dorado-Herrero N, Monsalvo S, Pérez-Balsera G, Fernández-Santos ME, Kwon M, Oarbeascoa G, Bastos-Oreiro M, Falero C, Pascual Izquierdo C, Muñoz-Martínez C, Pérez-Martínez A, Diez-Martin JL, Anguita J. Rubio-Azpeitia E, et al. Among authors: oarbeascoa g. Transfusion. 2022 Feb;62(2):374-385. doi: 10.1111/trf.16790. Epub 2022 Jan 13. Transfusion. 2022. PMID: 35023148
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.
Gómez-Centurión I, Oarbeascoa G, García MC, López Fresneña MC, Martínez Carreño MJ, Escudero Vilaplana V, González-Haba E, Bailén R, Dorado N, Juárez LM, Rodríguez Macías G, Font López P, Encinas C, Bastos-Oreiro M, Anguita J, Sanjurjo M, Díez-Martin JL, Kwon M. Gómez-Centurión I, et al. Among authors: oarbeascoa g. Int J Hematol. 2022 Jan;115(1):61-68. doi: 10.1007/s12185-021-03219-2. Epub 2021 Sep 22. Int J Hematol. 2022. PMID: 34553338 Free PMC article.
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
Bailén R, Pascual-Cascón MJ, Guerreiro M, López-Corral L, Chinea A, Bermúdez A, Sampol A, Heras I, García-Torres E, Torres M, Roca JR, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, López-Godino O, Martín-Calvo C, Fernández-Caldas P, Marcos-Jubilar M, Sánchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Díez-Martín JL, Kwon M; Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH). Bailén R, et al. Among authors: oarbeascoa g. Transplant Cell Ther. 2022 Apr;28(4):204.e1-204.e10. doi: 10.1016/j.jtct.2022.01.020. Epub 2022 Jan 31. Transplant Cell Ther. 2022. PMID: 35108627 Free article.
FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia.
Carbonell D, Chicano M, Cardero AJ, Gómez-Centurión I, Bailén R, Oarbeascoa G, Martínez-Señarís D, Franco C, Muñiz P, Anguita J, Kwon M, Díez-Martín JL, Buño I, Martínez-Laperche C. Carbonell D, et al. Among authors: oarbeascoa g. Cancers (Basel). 2022 Aug 19;14(16):4006. doi: 10.3390/cancers14164006. Cancers (Basel). 2022. PMID: 36010999 Free PMC article.
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
Bailén R, Vicario JL, Solán L, Sánchez-Vadillo I, Herrera P, Calbacho M, Alenda R, López-Lorenzo JL, Humala K, Chinea A, Sánchez-Pina J, Balas A, Moreno MÁ, Arzuaga J, Pradillo V, Dorado N, Oarbeascoa G, Anguita J, Díez-Martín JL, Kwon M. Bailén R, et al. Among authors: oarbeascoa g. Front Immunol. 2021 May 19;12:674658. doi: 10.3389/fimmu.2021.674658. eCollection 2021. Front Immunol. 2021. PMID: 34093576 Free PMC article.
20 results